Breakthrough cancer drug can kill
Breakthrough cancer drug can kill!
It's only been a few months since the drug Avastin (bevacizumab) was hailed as a great breakthrough drug for cancer therapy. The first drug designed to inhibit angiogenesis, it stops formation of new blood vessels that develop and which would carry vital nutrients to a tumor. By inhibiting angiogenesis the drug starves the tumor.
The United States Food and Drug Administration (FDA), approved it in February as part of the treatment for cancer of the colon or rectum.
In a mere five months of use, doctors have discovered the drug can cause stroke, heart attacks and angina, and it can also double the risk of a fatal thrombosis.
When it was approved the FDA knew the drug could cause fatal stomach perforations, fatal hemorrhage, hypertension and congestive heart failure.
Such new discoveries should raise concern about the efficacy and reliability of the pre-licensing clinical trials that too often appear to miss adverse reactions that could even kill the patient.
Another contest between the toxicologist and the undertaker as to who will win out. Perhaps it would be best to suffer with the cancer rather than roll the dice with this drug.
(Source: Food and Drug Administration website).
Comment:
What ever happened to Catrix - the refined extract of bovine tracheal cartilage that was shown to do the same thing (but with out deadly side effects) as once reported in the Medical Post. - CW
See:
www.catrix.com/trials/renalcell.html
ww.catrix.com/trials/paststudies.html
Back to top of document